{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:17:11Z","timestamp":1792016231577,"version":"4.4.0"},"reference-count":36,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2024,3,29]]},"abstract":"<jats:p>Background: Perivascular spaces (PVS) are fluid-filled cavities surrounding small cerebral blood vessels. There are limited reports of enlarged PVS across the grey matter in manifest Huntington\u2019s disease (HD). Little is known about how PVS morphometry in the white matter may contribute to HD. Enlarged PVS have the potential to both contribute to HD pathology and affect the distribution and success of intraparenchymal and intrathecally administered huntingtin-lowering therapies. Objective: To investigate PVS morphometry in the global white matter across the spectrum of HD. Relationships between PVS morphometry and disease burden and severity measures were examined. Methods: White matter PVS were segmented on 3T T2\u200aW MRI brain scans of 33 healthy controls, 30 premanifest HD (pre-HD), and 32 early manifest HD (early-HD) participants from the Vancouver site of the TRACK-HD study. PVS count and total PVS volume were measured. Results: PVS total count slightly increased in pre-HD (p\u200a=\u200a0.004), and early-HD groups (p\u200a=\u200a0.005), compared to healthy controls. PVS volume, as a percentage of white matter volume, increased subtly in pre-HD compared to healthy controls (p\u200a=\u200a0.044), but not in early-HD. No associations between PVS measures and HD disease burden or severity were found. Conclusions: This study reveals relatively preserved PVS morphometry across the global white matter of pre-HD and early-HD. Subtle morphometric abnormalities are implied but require confirmation in a larger cohort. However, in conjunction with previous publications, further investigation of PVS in HD and its potential impact on future treatments, with a focus on subcortical grey matter, is warranted.<\/jats:p>","DOI":"10.3233\/jhd-231508","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T12:06:43Z","timestamp":1710850003000},"page":"91-101","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of Perivascular Space Morphometry Across the White Matter in Huntington\u2019s Disease Using MRI"],"prefix":"10.1177","volume":"13","author":[{"given":"Annabelle","family":"Coleman","sequence":"first","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie T.","family":"Langan","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY, USA"},{"name":"Biomedical Engineering and Imaging Institute at Mount Sinai School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Verma","sequence":"additional","affiliation":[{"name":"Biomedical Engineering and Imaging Institute at Mount Sinai School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Knights","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Sturrock","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael I.","family":"Scahill","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Z.","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"6","key":"10.3233\/JHD-231508_ref1","first-page":"971","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"The Huntington\u2019s Disease Collaborative Research GrouCell"},{"issue":"2","key":"10.3233\/JHD-231508_ref2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JHD-239001","article-title":"Huntington\u2019s disease clinical trials corner: August 2023","volume":"2","author":"Estevez-Fraga","year":"2023","journal-title":"J Huntingtons Dis"},{"issue":"6","key":"10.3233\/JHD-231508_ref3","doi-asserted-by":"crossref","first-page":"e890","DOI":"10.1212\/WNL.0000000000011121","article-title":"Association of dilated perivascular spaces and disease severity in patients with Huntington disease","volume":"96","author":"Chan","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.3233\/JHD-231508_ref4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41582-020-0312-z","article-title":"Perivascular spaces in the brain: Anatomy, physiology and pathology","volume":"16","author":"Wardlaw","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10.3233\/JHD-231508_ref5","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system \u2013 a beginner\u2019s guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem Res"},{"issue":"11","key":"10.3233\/JHD-231508_ref6","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cvr\/cvy113","article-title":"Understanding the role of the perivascular space in cerebral small vessel disease","volume":"114","author":"Brown","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"21","key":"10.3233\/JHD-231508_ref7","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1016\/j.neuron.2022.10.024","article-title":"Perivascular spaces and their role in neuroinflammation","volume":"110","author":"Ineichen","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.3233\/JHD-231508_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-021-00878-5","article-title":"Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer\u2019s continuum","volume":"13","author":"Vilor-Tejedor","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.3233\/JHD-231508_ref9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.21037\/qims-21-705","article-title":"Perivascular space is associated with brain atrophy in patients with multiple sclerosis","volume":"12","author":"Liu","year":"2022","journal-title":"Quant Imaging Med Surg"},{"issue":"8","key":"10.3233\/JHD-231508_ref10","doi-asserted-by":"crossref","first-page":"e01343","DOI":"10.1002\/brb3.1343","article-title":"Structural neuroimaging differentiates vulnerability from disease manifestation in Colombian families with Huntington\u2019s disease","volume":"9","author":"Vald\u00e9s Hern\u00e1ndez del","year":"2019","journal-title":"Brain Behav"},{"key":"10.3233\/JHD-231508_ref11","doi-asserted-by":"crossref","first-page":"102498","DOI":"10.1016\/j.nicl.2020.102498","article-title":"Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington\u2019s disease patients","volume":"28","author":"Bulk","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JHD-231508_ref12","doi-asserted-by":"crossref","first-page":"663898","DOI":"10.3389\/fphys.2021.663898","article-title":"Impaired cerebrovascular reactivity in Huntington\u2019s disease","volume":"12","author":"Chan","year":"2021","journal-title":"Front Physiol"},{"issue":"5334","key":"10.3233\/JHD-231508_ref13","first-page":"1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","author":"Di Figlia","year":"1997","journal-title":"Science. 277"},{"issue":"4","key":"10.3233\/JHD-231508_ref14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1523\/JNEUROSCI.1865-20.2020","article-title":"Mutant huntingtin is cleared from the brain via active mechanisms in Huntington disease","volume":"41","author":"Caron","year":"2021","journal-title":"J Neurosci"},{"issue":"2","key":"10.3233\/JHD-231508_ref15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/stem.3103","article-title":"Mesenchymal stem cells alleviate AQP-4-dependent glymphatic dysfunction and improve brain distribution of antisense oligonucleotides in BACHD mice","volume":"38","author":"Wu","year":"2020","journal-title":"Stem Cells"},{"key":"10.3233\/JHD-231508_ref17","doi-asserted-by":"crossref","first-page":"1021311","DOI":"10.3389\/fnins.2022.1021311","article-title":"A critical guide to the automated quantification of perivascular spaces in magnetic resonance imaging","volume":"16","author":"Pham","year":"2022","journal-title":"Front Neurosci"},{"key":"10.3233\/JHD-231508_ref18","doi-asserted-by":"crossref","first-page":"102120","DOI":"10.1016\/j.nicl.2019.102120","article-title":"Computational quantification of brain perivascular space morphologies: Associations with vascular risk factors and white matter hyperintensities. A study in the Lothian Birth Cohort 1936","volume":"25","author":"Ballerini","year":"2020","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.3233\/JHD-231508_ref19","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41598-018-19781-5","article-title":"Perivascular spaces segmentation in brain MRI using optimal 3D filtering","volume":"8","author":"Ballerini","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JHD-231508_ref21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuroimage.2016.03.076","article-title":"Segmentation of perivascular spaces in 7 T MR image using auto-context model with orientation-normalized features","volume":"134","author":"Park","year":"2016","journal-title":"Neuroimage"},{"issue":"1","key":"10.3233\/JHD-231508_ref22","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1038\/s41598-019-48910-x","article-title":"Image processing approaches to enhance perivascular space visibility and quantification using MRI","volume":"9","author":"Sepehrband","year":"2019","journal-title":"Sci Rep"},{"key":"10.3233\/JHD-231508_ref23","doi-asserted-by":"crossref","first-page":"846957","DOI":"10.3389\/fneur.2022.846957","article-title":"Semi-automated segmentation and quantification of perivascular spaces at 7 Tesla in COVID-19","volume":"13","author":"Langan","year":"2022","journal-title":"Front Neurol"},{"issue":"7","key":"10.3233\/JHD-231508_ref24","doi-asserted-by":"crossref","first-page":"e32598","DOI":"10.1002\/brb3.2598","article-title":"Perivascular spaces as a marker of psychological trauma in depression: A 7-Tesla MRI study","volume":"12","author":"Ranti","year":"2022","journal-title":"Brain Behav"},{"issue":"9","key":"10.3233\/JHD-231508_ref25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.3233\/JHD-231508_ref26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: The 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.3233\/JHD-231508_ref27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: Analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.3233\/JHD-231508_ref28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: Analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.3233\/JHD-231508_ref29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin Genet"},{"issue":"5","key":"10.3233\/JHD-231508_ref30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington\u2019s disease","volume":"41","author":"Penney","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JHD-231508_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington disease: Clinical care and evaluation","volume":"29","author":"Shoulson","year":"1979","journal-title":"Neurology"},{"issue":"3","key":"10.3233\/JHD-231508_ref32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","article-title":"Unified segmentation","volume":"26","author":"Ashburner","year":"2005","journal-title":"Neuroimage"},{"issue":"2","key":"10.3233\/JHD-231508_ref33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"issue":"8","key":"10.3233\/JHD-231508_ref34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.3233\/JHD-231508_ref35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/molecules25030482","article-title":"Huntington\u2019s disease: A review of the known PET imaging biomarkers and targeting radiotracers","volume":"25","author":"Cybulska","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.3233\/JHD-231508_ref36","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00259-021-05578-8","article-title":"Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington\u2019s disease","volume":"49","author":"Bertoglio","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.3233\/JHD-231508_ref37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: Potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JHD-231508_ref38","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-231508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:56:21Z","timestamp":1777452981000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-231508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":36,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jhd-231508","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}